TELA Bio, Inc. (TELA)
0.8301
+0.01
(+1.05%)
USD |
NASDAQ |
Sep 08, 16:00
0.85
+0.02
(+2.40%)
Pre-Market: 20:00
TELA Bio Net Income (Quarterly) : -11.26M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.26M |
| March 31, 2026 | -12.27M |
| December 31, 2025 | -9.041M |
| September 30, 2025 | -8.603M |
| June 30, 2025 | -9.923M |
| March 31, 2025 | -11.26M |
| December 31, 2024 | -9.208M |
| September 30, 2024 | -10.37M |
| June 30, 2024 | -12.60M |
| March 31, 2024 | -5.661M |
| December 31, 2023 | -12.89M |
| September 30, 2023 | -10.96M |
| June 30, 2023 | -10.79M |
| March 31, 2023 | -12.03M |
| December 31, 2022 | -9.979M |
| September 30, 2022 | -10.71M |
| June 30, 2022 | -12.74M |
| Date | Value |
|---|---|
| March 31, 2022 | -10.86M |
| December 31, 2021 | -8.619M |
| September 30, 2021 | -8.266M |
| June 30, 2021 | -8.255M |
| March 31, 2021 | -8.136M |
| December 31, 2020 | -7.79M |
| September 30, 2020 | -7.703M |
| June 30, 2020 | -6.081M |
| March 31, 2020 | -7.22M |
| December 31, 2019 | -6.532M |
| September 30, 2019 | -4.666M |
| June 30, 2019 | -5.261M |
| March 31, 2019 | -5.966M |
| December 31, 2018 | -7.391M |
| September 30, 2018 | -2.806M |
| June 30, 2018 | -5.924M |
| March 31, 2018 | -4.971M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 19.29M |
| Total Expenses (Quarterly) | 30.55M |
| EPS Diluted (Quarterly) | -0.1962 |
| Enterprise Value | 63.40M |
| Gross Profit Margin (Quarterly) | 72.28% |
| Profit Margin (Quarterly) | -58.38% |
| Earnings Yield | -93.35% |
| Normalized Earnings Yield | -91.89 |